FAM
ARCT icon

Formidable Asset Management’s Arcturus Therapeutics ARCT Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$156K Hold
14,700
0.03% 372
2025
Q1
$156K Sell
14,700
-3,500
-19% -$37.1K 0.03% 373
2024
Q4
$309K Sell
18,200
-100
-0.5% -$1.7K 0.05% 296
2024
Q3
$425K Sell
18,300
-500
-3% -$11.6K 0.07% 247
2024
Q2
$458K Buy
18,800
+900
+5% +$21.9K 0.07% 245
2024
Q1
$604K Buy
17,900
+2,350
+15% +$79.4K 0.1% 211
2023
Q4
$490K Buy
15,550
+500
+3% +$15.8K 0.1% 173
2023
Q3
$385K Buy
15,050
+100
+0.7% +$2.56K 0.09% 201
2023
Q2
$429K Hold
14,950
0.09% 185
2023
Q1
$384K Sell
14,950
-900
-6% -$23.1K 0.08% 200
2022
Q4
$269K Buy
15,850
+200
+1% +$3.39K 0.06% 241
2022
Q3
$261K Buy
15,650
+700
+5% +$11.7K 0.06% 234
2022
Q2
$235K Buy
14,950
+900
+6% +$14.1K 0.05% 254
2022
Q1
$379K Buy
14,050
+1,100
+8% +$29.7K 0.07% 224
2021
Q4
$498K Sell
12,950
-300
-2% -$11.5K 0.1% 188
2021
Q3
$633K Buy
13,250
+925
+8% +$44.2K 0.12% 166
2021
Q2
$346K Buy
12,325
+5,450
+79% +$153K 0.07% 207
2021
Q1
$278K Buy
+6,875
New +$278K 0.06% 223
2020
Q3
Sell
-4,866
Closed -$263K 267
2020
Q2
$263K Buy
+4,866
New +$263K 0.08% 194
2017
Q4
Sell
-13,435
Closed -$14K 116
2017
Q3
$14K Buy
+13,435
New +$14K 0.01% 195
2017
Q1
Sell
-13,785
Closed -$29K 193
2016
Q4
$29K Sell
13,785
-2,300
-14% -$4.84K 0.01% 169
2016
Q3
$40K Buy
16,085
+1,600
+11% +$3.98K 0.02% 166
2016
Q2
$61K Buy
+14,485
New +$61K 0.03% 157